FIGURE 1 This paper mainly discusses the basic antioxidant properties of EGT in animals and its close relationship with oxidative stress diseases, and summarizes the possible therapeutic or protective mechanisms of EGT, which may provide implications for future research directions and promote further application of EGT
This actin sequestration maintains a pool of mobile actin ready for rapid deployment when cells need to migrate or repair damage
This multi-receptor activation enables: GLP-1R activation enhances glucose-dependent insulin secretion and reduces appetite through hypothalamic signaling GIPR activation (highest potency: EC50 0.0643 nM) promotes insulin secretion and modulates lipid metabolism GCGR activation (EC50 5.79 nM) increases energy expenditure and promotes hepatic fat oxidation Combined receptor engagement produces dose-dependent reductions in body weight and improvements in glycemic control Research demonstrates that GLP3s balanced activation across three receptors produces superior metabolic effects compared to single or dual agonists, with phase 2 trials showing up to 24.2% weight reduction in 48 weeks[2]
These markers included four unidentified lipids, lysophosphatidylcholines (LPCs, 16:0, 18:0, 18:2, and 20:5), phosphatidylethanolamines (PEPs, P-18:0/22:5 and 20.1:20.4), cholesterol, an ether LPC (O-LPC 16:0), triglycerides (TGs, 51:20) and the ketogenic AA threonine [31]